Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

LIPO Lipella Pharmaceuticals Inc

2,26

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:08:38

Verzögert um 15 Minuten

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Lipella Pharmaceuticals (NASDAQ:LIPO)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more Lipella Pharmaceuticals Charts.

Lipella Pharmaceuticals (NASDAQ:LIPO)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more Lipella Pharmaceuticals Charts.

News Lipella Pharmaceuticals Inc

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Donnerstag 10 April 2025 (9 Stunden vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 9 April 2025 (13 Stunden vor) • Edgar (US Regulatory)

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus
Dienstag 8 April 2025 (2 Tage vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 8 April 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 7 April 2025 (3 Tage vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 4 April 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 4 April 2025 (6 Tage vor) • Edgar (US Regulatory)

Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast
Montag 31 März 2025 (1 Woche vor) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Freitag 28 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Mittwoch 19 März 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 18 März 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dienstag 18 März 2025 (3 Wochen vor) • Edgar (US Regulatory)

Weitere Lipella Pharmaceuticals Inc News-Artikel

Rivian Automotive

Amundi Index Sol Amundi ...

Acadia Pharmaceuticals

Bayerische Motoren Werke

Direxion Daily AAPL Bull...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen